Loading data
AVNTNYSE
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 3.26 bn USD | 3.24 bn USD | 3.14 bn USD | 3.4 bn USD | 3.32 bn USD |
| Cost of revenue | 2.24 bn USD | 2.18 bn USD | 2.25 bn USD | 2.51 bn USD | 2.37 bn USD |
| Gross profit | 1.02 bn USD | 1.06 bn USD | 892.5 m USD | 882.7 m USD | 943.8 m USD |
| Research and development expense | 96.7 m USD | 98.7 m USD | 90.3 m USD | 84.9 m USD | 83.2 m USD |
| Selling, general and administrative expense | 812.1 m USD | 727.4 m USD | 695.7 m USD | 639.4 m USD | 664.1 m USD |
| Operating profit | 203.5 m USD | 329.3 m USD | 196.8 m USD | 243.3 m USD | 279.7 m USD |
| Profit before tax | 111.7 m USD | 224.8 m USD | 87.3 m USD | 63.8 m USD | 203.5 m USD |
| Income tax expense | 28.1 m USD | 54.1 m USD | 11 m USD | -19.3 m USD | 51.9 m USD |
| Net income (reported basis) | 83.6 m USD | 170.7 m USD | 76.2 m USD | 703.4 m USD | 230.6 m USD |
| Basic earnings per share | 0.9 USD/share | 1.86 USD/share | 0.83 USD/share | 7.71 USD/share | 2.53 USD/share |
| Diluted earnings per share | 0.89 USD/share | 1.84 USD/share | 0.83 USD/share | 7.63 USD/share | 2.51 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.